All FLT4 reagents are produced in house and quality controlled, including 9 FLT4 Antibody, 2 FLT4 ELISA, 29 FLT4 Gene, 4 FLT4 Lysate, 4 FLT4 Protein, 2 FLT4 qPCR. All FLT4 reagents are ready to use.
Recombinant FLT4 proteins are expressed by HEK293 Cells with fusion tags as C-human IgG1-Fc, C-His.
FLT4antibodies are validated with different applications, which are ELISA, WB, ELISA(Cap), ELISA(Det).
FLT4cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each FLT4 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.
FLT4ELISA Kit are quality controlled by 8 internation QC standard which guarantee every ELISA Kit with high quality.
Vascular endothelial growth factor receptor 3 (VEGFR3), also known as FLT-4, together with the other two members VEGFR1 (FLT-1) and VEGFR2 (KDR/Flk-1) are receptors for vascular endothelial growth factors (VEGF) and belong to the class III subfamily of receptor tyrosine kinases (RTKs). The VEGFR3 protein is expressed mainly on lymphatic vessels but it is also up-regulated in tumor angiogenesis. Mutations in VEGFR3 have been identified in patients with primary lymphoedema. The VEGF-C/VEGF-D/VEGFR3 signaling pathway may provide a target for antilymphangiogenic therapy in prostate cancer, breast cancer, gastric cancer, lung cancer, non-small cell lung cancer (NSCLC), and so on.